Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: F. Jay Abella, III who wrote (4175)	5/15/1998 7:23:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Jay: Is that a typo where you said Viagra one to two hours? In context it sounded like you meant Vasomax, though Viagra IS one to two hours. As for the earnings report I was interested in the fact some other drug of theirs may not be working out. I don't really expect them to be making money now, without a drug to sell, so the negative earnings were no surprise. They have a good cash position thanks to their deal with SGP, I think. I thought you wrote a fair criticism, since some have suggested that the reason Vasomax might do well on the market, is that it is much faster acting than Viagra. But this suggests it's not that much faster acting after all (if it works at all). Linda